228 related articles for article (PubMed ID: 28487237)
1. Cytokines affecting CD4
Nomura M; Hodgkinson SJ; Tran GT; Verma ND; Robinson C; Plain KM; Boyd R; Hall BM
Transpl Immunol; 2017 Jun; 42():24-33. PubMed ID: 28487237
[TBL] [Abstract][Full Text] [Related]
2. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
[TBL] [Abstract][Full Text] [Related]
3. Cytokines affecting CD4
Hall BM; Plain KM; Tran GT; Verma ND; Robinson CM; Nomura M; Boyd R; Hodgkinson SJ
Transpl Immunol; 2017 Aug; 43-44():33-41. PubMed ID: 28652007
[TBL] [Abstract][Full Text] [Related]
4. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
5. Alloactivation of Naïve CD4
Verma ND; Robinson CM; Carter N; Wilcox P; Tran GT; Wang C; Sharland A; Nomura M; Plain KM; Bishop GA; Hodgkinson SJ; Hall BM
Front Immunol; 2019; 10():2397. PubMed ID: 31681288
[TBL] [Abstract][Full Text] [Related]
6. Changes in Reactivity
Hall BM; Robinson CM; Plain KM; Verma ND; Tran GT; Nomura M; Carter N; Boyd R; Hodgkinson SJ
Front Immunol; 2017; 8():994. PubMed ID: 28878770
[TBL] [Abstract][Full Text] [Related]
7. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. V. Dependence of CD4+ suppressor cells on the presence of alloantigen and cytokines, including interleukin 2.
Pearce NW; Spinelli A; Gurley KE; Hall BM
Transplantation; 1993 Feb; 55(2):374-80. PubMed ID: 8434390
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses.
Verma ND; Plain KM; Nomura M; Tran GT; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
Blood; 2009 Jan; 113(2):479-87. PubMed ID: 18827184
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ T Regulatory Cells in Transplantation Tolerance: 25 Years On.
Hall BM
Transplantation; 2016 Dec; 100(12):2533-2547. PubMed ID: 27861285
[TBL] [Abstract][Full Text] [Related]
11. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. VI. In vitro alloreactivity of T cell subsets from rats with long-surviving allografts.
Pearce NW; Berger MF; Gurley KE; Spinelli A; Hall BM
Transplantation; 1993 Feb; 55(2):380-9. PubMed ID: 8434391
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
[TBL] [Abstract][Full Text] [Related]
13. Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures.
Hall BM; Robinson CM; Plain KM; Verma ND; Carter N; Boyd RA; Tran GT; Hodgkinson SJ
Transpl Immunol; 2008 Feb; 18(4):291-301. PubMed ID: 18158114
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4
Hall BM; Hall RM; Tran GT; Robinson CM; Wilcox PL; Rakesh PK; Wang C; Sharland AF; Verma ND; Hodgkinson SJ
Front Immunol; 2021; 12():714838. PubMed ID: 34912327
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells.
Pearce NW; Spinelli A; Gurley KE; Dorsch SE; Hall BM
J Immunol; 1989 Jul; 143(2):499-506. PubMed ID: 2472441
[TBL] [Abstract][Full Text] [Related]
17. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ
J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127
[TBL] [Abstract][Full Text] [Related]
18. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients.
Verma ND; Hall BM; Plain KM; Robinson CM; Boyd R; Tran GT; Wang C; Bishop GA; Hodgkinson SJ
Front Immunol; 2014; 5():190. PubMed ID: 24847323
[TBL] [Abstract][Full Text] [Related]
20. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
